Annual EBITDA
-$83.23 M
-$44.66 M-115.76%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual EBITDA is -$83.23 million, with the most recent change of -$44.66 million (-115.76%) on December 31, 2023.
- During the last 3 years, ELVN annual EBITDA has fallen by -$73.96 million (-797.57%).
- ELVN annual EBITDA is now -797.57% below its all-time high of -$9.27 million, reached on December 1, 2020.
Performance
ELVN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$26.99 M
-$2.46 M-10.04%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly EBITDA is -$26.99 million, with the most recent change of -$2.46 million (-10.04%) on September 30, 2024.
- Over the past year, ELVN quarterly EBITDA has dropped by -$1.08 million (-4.17%).
- ELVN quarterly EBITDA is now -222.75% below its all-time high of -$8.36 million, reached on December 1, 2021.
Performance
ELVN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$100.07 M
-$2.82 M-2.90%
September 30, 2024
Summary
- As of February 7, 2025, ELVN TTM EBITDA is -$100.07 million, with the most recent change of -$2.82 million (-2.90%) on September 30, 2024.
- Over the past year, ELVN TTM EBITDA has dropped by -$7.28 million (-7.85%).
- ELVN TTM EBITDA is now -1096.75% below its all-time high of -$8.36 million, reached on December 1, 2021.
Performance
ELVN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ELVN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -115.8% | -4.2% | -7.8% |
| 3 y3 years | -797.6% | -65.0% | -116.2% |
| 5 y5 years | -797.6% | -65.0% | -116.2% |
ELVN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -237.7% | at low | -222.8% | at low | -1096.8% | at low |
| 5 y | 5-year | -797.6% | at low | -222.8% | at low | -1096.8% | at low |
| alltime | all time | -797.6% | at low | -222.8% | at low | -1096.8% | at low |
Enliven Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$26.99 M(+10.0%) | -$100.07 M(+2.9%) |
| Jun 2024 | - | -$24.52 M(-5.3%) | -$97.25 M(+4.8%) |
| Mar 2024 | - | -$25.91 M(+14.4%) | -$92.79 M(+11.5%) |
| Dec 2023 | -$83.23 M(+115.8%) | -$22.65 M(-6.3%) | -$83.23 M(+17.8%) |
| Sep 2023 | - | -$24.17 M(+20.5%) | -$70.68 M(+23.2%) |
| Jun 2023 | - | -$20.06 M(+22.7%) | -$57.38 M(+24.0%) |
| Mar 2023 | - | -$16.35 M(+61.9%) | -$46.29 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$38.58 M(+56.5%) | -$10.10 M(-7.1%) | -$38.58 M(+4.7%) |
| Sep 2022 | - | -$10.87 M(+21.3%) | -$36.84 M(+41.9%) |
| Jun 2022 | - | -$8.96 M(+3.8%) | -$25.96 M(+52.7%) |
| Mar 2022 | - | -$8.64 M(+3.3%) | -$17.00 M(+103.3%) |
| Dec 2021 | -$24.65 M(+165.8%) | - | - |
| Dec 2021 | - | -$8.36 M | -$8.36 M |
| Dec 2020 | -$9.27 M | - | - |
FAQ
- What is Enliven Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Enliven Therapeutics?
- What is Enliven Therapeutics annual EBITDA year-on-year change?
- What is Enliven Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly EBITDA year-on-year change?
- What is Enliven Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Enliven Therapeutics?
- What is Enliven Therapeutics TTM EBITDA year-on-year change?
What is Enliven Therapeutics annual EBITDA?
The current annual EBITDA of ELVN is -$83.23 M
What is the all time high annual EBITDA for Enliven Therapeutics?
Enliven Therapeutics all-time high annual EBITDA is -$9.27 M
What is Enliven Therapeutics annual EBITDA year-on-year change?
Over the past year, ELVN annual EBITDA has changed by -$44.66 M (-115.76%)
What is Enliven Therapeutics quarterly EBITDA?
The current quarterly EBITDA of ELVN is -$26.99 M
What is the all time high quarterly EBITDA for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly EBITDA is -$8.36 M
What is Enliven Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ELVN quarterly EBITDA has changed by -$1.08 M (-4.17%)
What is Enliven Therapeutics TTM EBITDA?
The current TTM EBITDA of ELVN is -$100.07 M
What is the all time high TTM EBITDA for Enliven Therapeutics?
Enliven Therapeutics all-time high TTM EBITDA is -$8.36 M
What is Enliven Therapeutics TTM EBITDA year-on-year change?
Over the past year, ELVN TTM EBITDA has changed by -$7.28 M (-7.85%)